Identification of evolutionarily stable sites across the SARS-CoV-2 proteome
Authors:
- Chen WangCWChen Wang
- Daniel M. KoneckiDKDaniel M. Konecki
- David C. MarcianoDMDavid C. Marciano
- Harikumar GovindarajanHGHarikumar Govindarajan
- Amanda M. WilliamsAWAmanda M. Williams
- Brigitta WastuwidyaningtyasBWBrigitta Wastuwidyaningtyas
- Thomas BourquardTBThomas Bourquard
- Panagiotis KatsonisPanagiotis Katsonis
- Olivier LichtargeOLOlivier Lichtarge
Preprint
- 20 October 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Since the first recognized case of COVID-19, more than 30 million people have been infected worldwide. Despite global efforts in drug and vaccine development to fight the disease, there is currently no vaccine or drug cure for COVID-19, though some drugs reduce severity and hasten recovery. Here we interrogate the evolutionary history of the entire SARS-CoV-2 proteome to identify functional sites that can inform the search for treatments. Combining this information with the mutations observed in the current COVID-19 outbreak, we systematically and comprehensively define evolutionarily stable sites that are useful drug targets. Several experimentally-validated effective drugs interact with these proposed target sites. In addition, the same evolutionary information can prioritize cross reactive antigens that are useful in directing multi-epitope vaccine strategies to illicit broadly neutralizing immune responses to the betacoronavirus family. Although the results are focused on SARS-CoV-2, these approaches are based upon evolutionary principles and are agnostic to organism or infective agent.Keywords
All Related Versions
This publication has 82 references indexed in Scilit:
- Prediction and experimental validation of enzyme substrate specificity in protein structuresProceedings of the National Academy of Sciences, 2013
- Accounting for epistatic interactions improves the functional analysis of protein structuresBioinformatics, 2013
- Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion CompetenceViruses, 2012
- Crystal Structure and Functional Analysis of the SARS-Coronavirus RNA Cap 2′-O-Methyltransferase nsp10/nsp16 ComplexPLOS Pathogens, 2011
- Sequence and structure continuity of evolutionary importance improves protein functional site discovery and annotationProtein Science, 2010
- Evolution-guided discovery and recoding of allosteric pathway specificity determinants in psychoactive bioamine receptorsProceedings of the National Academy of Sciences, 2010
- Characterization of a Highly Conserved Domain within the Severe Acute Respiratory Syndrome Coronavirus Spike Protein S2 Domain with Characteristics of a Viral Fusion PeptideJournal of Virology, 2009
- Background frequencies for residue variability estimates: BLOSUM revisitedBMC Bioinformatics, 2007
- A Family of Evolution–Entropy Hybrid Methods for Ranking Protein Residues by ImportanceJournal of Molecular Biology, 2004
- An Evolutionary Trace Method Defines Binding Surfaces Common to Protein FamiliesJournal of Molecular Biology, 1996